Literature DB >> 16044439

Diagnosis of deep vein thrombosis by plasma-soluble fibrin or D-dimer.

Satoshi Ota1, Hideo Wada, Tsutomu Nobori, Toshihiko Kobayashi, Midori Nishio, Yukiko Nishioka, Maki Noda, Akane Sakaguchi, Yasunori Abe, Junji Nishioka, Ken Ishikura, Norikazu Yamada, Takeshi Nakano.   

Abstract

The present study was designed to determine the cutoff values of D-dimer and soluble fibrin (SF) for the diagnosis of deep venous thrombosis (DVT) and pulmonary embolism (PE) in Japanese patients. Plasma levels of these molecules were measured in 243 patients suspected of having DVT and 100 healthy volunteers (controls). Out of 243 patients, 20 patients were diagnosed with DVT. In the control group, plasma levels of D-dimer and SF did not show normal distribution, and the 95% confidence intervals (CI) of D-dimer and SF were 2.45 microg/mL and 6.92 microg/mL, respectively. Plasma levels of D-dimer and SF of patients with DVT were significantly higher than of those without DVT. In patients with DVT, the minimum values of D-dimer and SF were 1.71 and 1.44 microg/mL, respectively. When the cutoff value was set at the average+1 SD of those of the control (D-dimer, about 1.8 microg/mL; SF, about 1.4 microg/mL), 1 and 0 patient with DVT was overlooked, respectively. The sensitivity and specificity of D-dimer and SF for DVT were 95% and 100%, and 61.9% and 53.8%, respectively. When the cutoff value was set at 95% CI of the control (D-dimer, 2.5 microg/mL; SF, 6.9 microg/mL), 2 and 9 patients with DVT were overlooked, respectively. The sensitivity and specificity of D-dimer and SF were 90% and 50%, and 77.6% and 88.3%, respectively. When the cutoff values set at 2.5 microg/mL of D-dimer or 6.9 microg/mL of SF, 1 DVT patient was overlooked, with sensitivity and specificity of 95% and 69.5%. Our data suggest that both D-dimer and SF are useful markers for the diagnosis of DVT and that measurement of both D-dimer and SF increases the sensitivity and specificity for the diagnosis of DVT/PE. Copyright (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16044439     DOI: 10.1002/ajh.20396

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  15 in total

1.  D-dimer for the diagnosis of acute venous thromboembolism in the emergency department: a Janus-face marker.

Authors:  Roberto Manfredini
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

2.  Negative predictive value of D-dimer for diagnosis of venous thromboembolism.

Authors:  Hideki Nomura; Hideo Wada; Toshiro Mizuno; Naoyuki Katayama; Yasunori Abe; Maki Noda; Kaname Nakatani; Takeshi Matsumoto; Satoshi Ota; Norikazu Yamada; Akihiro Sudo; Atsumasa Uchida; Tsutomu Nobori
Journal:  Int J Hematol       Date:  2008-02-19       Impact factor: 2.490

3.  Cut-off values of D-dimer and soluble fibrin for prediction of deep vein thrombosis after orthopaedic surgery.

Authors:  Akihiro Sudo; Hideo Wada; Tsutomu Nobori; Norikazu Yamada; Masaaki Ito; Rui Niimi; Masahiro Hasegawa; Koji Suzuki; Atsumasa Uchida
Journal:  Int J Hematol       Date:  2009-05-09       Impact factor: 2.490

4.  Mean platelet volume and D-dimer in patients with suspected deep venous thrombosis.

Authors:  Arzu Canan; Siddıka Sezgin Halıcioğlu; Safiye Gürel
Journal:  J Thromb Thrombolysis       Date:  2012-08       Impact factor: 2.300

5.  Silent venous thromboembolism in multiple myeloma patients treated with lenalidomide.

Authors:  Atsushi Isoda; Naru Sato; Yuri Miyazawa; Yoshinobu Matsumoto; Mina Koumoto; Masahito Ookawa; Morio Sawamura; Morio Matsumoto
Journal:  Int J Hematol       Date:  2015-07-16       Impact factor: 2.490

6.  Evaluation of D-Dimer in Screening Deep Vein Thrombosis in Hospitalized Japanese Patients with Acute Medical Diseases/Episodes.

Authors:  Hiroshi Matsuo; Yoshie Nakajima; Tomohiro Ogawa; Makoto Mo; Junichi Tazaki; Takahiro Doi; Norikazu Yamada; Takeo Suzuki; Hiromu Nakajima
Journal:  Ann Vasc Dis       Date:  2016-07-19

7.  Cerebral venous sinus thrombosis in an adolescent with Ewing sarcoma.

Authors:  Ekrem Unal; Abdullah Yazar; Yavuz Koksal; Umran Caliskan; Yahya Paksoy; Erdal Kalkan
Journal:  Childs Nerv Syst       Date:  2008-05-15       Impact factor: 1.475

8.  Elevated levels of soluble fibrin in patients with venous thromboembolism.

Authors:  Akihiro Tsuji; Hideo Wada; Takeshi Matsumoto; Yasunori Abe; Satoshi Ota; Norikazu Yamada; Takashi Sugiyama; Akihiro Sudo; Katsuya Onishi; Kaname Nakatani; Atsumasa Uchida; Masaaki Ito; Koji Suzuki; Tsutomu Nobori
Journal:  Int J Hematol       Date:  2008-10-04       Impact factor: 2.490

9.  Resolution of left atrial appendage thrombus with apixaban.

Authors:  Tohru Kawakami; Hiroko Kobayakawa; Hiroyoshi Ohno; Nobukiyo Tanaka; Hiroki Ishihara
Journal:  Thromb J       Date:  2013-12-20

10.  The role of soluble fibrin during anticoagulant therapy: a case report.

Authors:  Tohru Kawakami; Nobukiyo Tanaka; Hiroki Ishihara; Hiroyoshi Ohno
Journal:  Thromb J       Date:  2015-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.